Literature DB >> 7492441

Expression and purification of the HIV type 1 Rev protein produced in Escherichia coli and its use in the generation of monoclonal antibodies.

M J Orsini1, A N Thakur, W W Andrews, M L Hammarskjöld, D Rekosh.   

Abstract

We have developed a simple and rapid procedure for the purification of large amounts of Rev protein overexpressed in E. coli. The purification method, which does not require denaturation of the protein, takes advantage of the positively charged nature of Rev and the ability of Rev to interact with nucleic acids. The purified protein was used to develop three novel murine monoclonal antibodies against Rev. Using fusion proteins between glutathione S-transferase (GST) and various fragments of the Rev protein, we mapped the specificity of these antibodies to different regions of the Rev protein. One antibody, 3H6, is directed against the nucleolar localization/RRE-binding domain of Rev between amino acids 38 and 44. Another antibody, 3G4, recognizes an epitope between amino acids 90 and 116 of Rev. A third antibody, 2G2, does not recognize any of the fusion proteins, and may be directed against a conformational epitope. All three antibodies are able to detect Rev on Western blots and to immunoprecipitate Rev under native conditions. However, only 3H6 and 3G4 immunoprecipitate Rev under denaturing conditions and are able to detect Rev expressed in transfected cells by indirect immunofluorescence. These antibodies should prove useful in further studies of Rev function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7492441     DOI: 10.1089/aid.1995.11.945

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  8 in total

1.  The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines.

Authors:  N Srinivasakumar; N Chazal; C Helga-Maria; S Prasad; M L Hammarskjöld; D Rekosh
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  In vitro selection of ribozymes dependent on peptides for activity.

Authors:  Michael P Robertson; Scott M Knudsen; Andrew D Ellington
Journal:  RNA       Date:  2004-01       Impact factor: 4.942

3.  Molding a peptide into an RNA site by in vivo peptide evolution.

Authors:  K Harada; S S Martin; R Tan; A D Frankel
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

4.  Selection and characterization of human immunodeficiency virus type 1 mutants that are resistant to inhibition by the transdominant negative RevM10 protein.

Authors:  T E Hamm; D Rekosh; M L Hammarskjöld
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

5.  NXT1 (p15) is a crucial cellular cofactor in TAP-dependent export of intron-containing RNA in mammalian cells.

Authors:  B W Guzik; L Levesque; S Prasad; Y C Bor; B E Black; B M Paschal; D Rekosh; M L Hammarskjöld
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

6.  Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity.

Authors:  N K Jana; L R Gray; D C Shugars
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

7.  Rapid and efficient purification of RNA-binding proteins: application to HIV-1 Rev.

Authors:  Marco Marenchino; David W Armbruster; Mirko Hennig
Journal:  Protein Expr Purif       Date:  2008-09-25       Impact factor: 1.650

8.  Nuclear Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function.

Authors:  Silvio Urcuqui-Inchima; Maria Eugenia Castaño; Danièle Hernandez-Verdun; Georges St-Laurent; Ajit Kumar
Journal:  Retrovirology       Date:  2006-11-24       Impact factor: 4.602

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.